Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study
Heesun J. Rogers(Cleveland Clinic), Eric D. Hsi(Mayo Clinic), Athena M. Cherry(Stanford Health Care), Pei Lin(Sun Yat-sen University), Robert P. Hasserjian(Massachusetts General Hospital), Jennifer J.D. Morrissette(University of Pennsylvania), S. A. Wang(The University of Texas MD Anderson Cancer Center), Natasha M. Savage(Stanford University), S Mathew(Memorial Sloan Kettering Cancer Center), Attilio Orazi(Texas Tech University), Erika M. Moore(University of Pennsylvania), Daniel A. Arber(University of Chicago), John Anastasi(Brown University), Adam Bagg(University of Pennsylvania), Gordana Raca(University of Southern California), Y.-C. Liu(Cornell University), Ramón V. Tiu(Eli Lilly (United States)), J. W. Vardiman(Stanford University), Kathryn Foucar(University of New Mexico), Carlo E. Bueso-Ramos(The University of Texas MD Anderson Cancer Center), Matthew Karafa(Cleveland Clinic)
Cited by 85
Related Papers
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
|Blood|2016|10.2k
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k